| Net income (loss) | 263.84M |
| Depreciation and amortization | 74.56M |
| Deferred income taxes | 7.63M |
| Restructuring charges related to the reassessment of the residual value guarantee recorded in other long-term liabilities | |
| Equity-based compensation expense | 38.6M |
| Income tax benefit on equity-based compensation plans | |
| Excess tax benefit on equity-based compensation plans | 0 |
| Amortization of convertible note discount | |
| Goodwill impairment | |
| Other, net | |
| Accounts receivable, net of allowance | |
| Inventories | |
| Prepaid expenses and other assets | |
| Trade accounts payable | |
| Net cash provided by (used for) operating activities | |
| Capital expenditures and intangible assets | -41.98M |
| Acquisitions of business, net of cash acquired | |
| Purchases of available-for-sale securities | -38.15M |
| Sales and maturities of available-for-sale securities | 469.9M |
| Purchase of other investments | |
| Proceeds from sale of assets | |
| Transfer of restricted cash and investments | -5.22M |
| Net cash provided by (used for) investing activities | |
| Principal payments on long-term debt and capital lease obligations | -371K |
| Net proceeds from issuance of long-term debt & convertible notes | |
| Proceeds from sale of warrants | |
| Excess tax benefit on equity-based compensation plans | 0 |
| Treasury stock purchases | -1.85M |
| Net cash received in settlement of (paid in advance for) stock repurchase contracts | |
| Reissuances of treasury stock | 19.32M |
| Proceeds from issuance of common stock | 1.46M |
| Net cash provided by (used for) financing activities | |
| Effect of exchange rate changes on cash | 1.91M |
| Net increase (decrease) in cash and cash equivalents | 822.38M |
| Cash and cash equivalents at beginning of year | 5.04B |
| Cash and cash equivalents at end of year | 5.86B |
| Cash payments for income taxes | |